Skip to main content
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.960
-0.030 (-3.05%)
At close: Feb 27, 2026, 4:00 PM EST
0.950
-0.010 (-1.02%)
After-hours: Feb 27, 2026, 7:56 PM EST

aTyr Pharma Revenue

aTyr Pharma had revenue of $190.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $190.00K, down -19.15% year-over-year. In the year 2024, aTyr Pharma had annual revenue of $235.00K, down -33.43%.

Revenue (ttm)
$190.00K
Revenue Growth
-19.15%
P/S Ratio
494.99
Revenue / Employee
$2,923
Employees
65
Market Cap
94.05M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024235.00K-118.00K-33.43%
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 2021---
Dec 31, 202010.46M10.03M2,377.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 52.93M
Gossamer Bio 44.05M
Pyxis Oncology 2.82M
Kazia Therapeutics 1.20M
Precision BioSciences 698.00K
Revenue Rankings

ATYR News

More News